Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders
Dicson Sheeja Malar, Premrutai Thitilertdecha, Kanokphorn S Ruckvongacheep, et al.
CNS Drugs (2023) Vol. 37, Iss. 5, pp. 399-440
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Multi-target drugs for Alzheimer's disease
Bengisu Turgutalp, Çağhan Kızıl
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 7, pp. 628-638
Closed Access | Times Cited: 14
Brain-Derived Neurotrophic Factor (BDNF) as a Marker of Physical Exercise or Activity Effectiveness in Fatigue, Pain, Depression, and Sleep Disturbances: A Scoping Review
Nada Lukkahatai, Irvin L. Ong, Chitchanok Benjasirisan, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 332-332
Open Access | Times Cited: 1
Astrocyte-specific activation of sigma-1 receptors in mPFC mediates the faster onset antidepressant effect by inhibiting NF-κB-induced neuroinflammation
Jingya Wang, Peng Ren, Lin-Yu Cui, et al.
Brain Behavior and Immunity (2024) Vol. 120, pp. 256-274
Closed Access | Times Cited: 7
The Sigma Receptors in Alzheimer’s Disease: New Potential Targets for Diagnosis and Therapy
Tao Wang, Hongmei Jia
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12025-12025
Open Access | Times Cited: 15
Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now?
Lisa Sequeira, Sofia Benfeito, Carlos Fernandes, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 708-708
Open Access | Times Cited: 5
Intravenous Nanoemulsions Loaded with Phospholipid Complex of a Novel Pyrazoloquinolinone Ligand for Enhanced Brain Delivery
Tijana Stanković, Jela Milić, Branka Divović, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 232-232
Open Access
Sigma-1 receptors and geriatric pharmacology
James Michael Brimson, Sirikalaya Brimson
Geriatric Pharmacology (2025) Vol. 1, Iss. sup1
Open Access
Social and contextual memory impairments induced by Amyloid-β oligomers are rescued by Sigma-1 receptor activation
Souhail Djebari, Raquel Jiménez‐Herrera, Guillermo Iborra‐Lázaro, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117914-117914
Open Access
A molecular systems architecture of neuromuscular junction in amyotrophic lateral sclerosis
V. A. Shiva Ayyadurai, Prabhakar Deonikar, Roger D. Kamm
npj Systems Biology and Applications (2025) Vol. 11, Iss. 1
Open Access
Agarwood leaf ethanol extract provides neuroprotective properties and promotes cholinergic differentiation of HT22 hippocampal neurons
Kishoree Krishna Kumaree, James Michael Brimson, Kanika Verma, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Sigma-1 receptor as an emerging target for painful diabetic neuropathy—a review
Youyi Peng, Qiang Zhang, Shan Chen
Exploration of neuroscience (2025) Vol. 4
Open Access
Sigma-1 Receptor Inhibition Reduces Mechanical Allodynia and Modulate Neuroinflammation in Chronic Neuropathic Pain
Simona Denaro, Lorella Pasquinucci, Rita Turnaturi, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 5, pp. 2672-2685
Open Access | Times Cited: 12
Current therapeutics for Alzheimer’s disease and clinical trials
Danqing Xiao, Chen Zhang
Exploration of neuroscience (2024) Vol. 3, Iss. 3, pp. 255-271
Open Access | Times Cited: 4
Afobazole alleviates streptozotocin-induced diabetic nephropathy in rats via hypoglycemic, antioxidant, anti-inflammatory, and anti-apoptotic properties: Role of the S1R/Nrf2 antioxidant axis
Alaa S. Wahba, Dalia M. Asal, Noha M. Mesbah, et al.
Life Sciences (2025) Vol. 363, pp. 123410-123410
Closed Access
Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now?
Lisa Sequeira, Sofia Benfeito, Carlos Fernandes, et al.
(2024)
Open Access | Times Cited: 3
Molecular Imaging of Alzheimer’s Disease-Related Sigma-1 Receptor in the Brain via a Novel Ru-Mediated Aromatic 18F-deoxyfluorination Probe
Ping Bai, Frederick A. Bagdasarian, Yulong Xu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6207-6217
Closed Access | Times Cited: 3
Simple ammonium salt and sigma-1 receptor ligand dipentylammonium provides neuroprotective effects in cell culture and Caenorhabditis elegans models of Alzheimer's disease
Mani Iyer Prasanth, Kanika Verma, Sirikalaya Brimson, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116455-116455
Open Access | Times Cited: 2
Exploring Structural Requirements for Sigma-1 Receptor Linear Ligands: Experimental and Computational Approaches
Lisa Lombardo, Salvatore Mirabile, Rosaria Gitto, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 14, pp. 5701-5711
Closed Access | Times Cited: 2
Sigma Receptors: Novel Regulators of Iron/Heme Homeostasis and Ferroptosis
Nhi Nguyen, Valeria Jaramillo‐Martinez, Marilyn Mathew, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14672-14672
Open Access | Times Cited: 5
2-(Piperidin-3-yl)phthalimides reduce classical markers of cellular inflammation in LPS-challenged RAW 264.7 cells and also demonstrate potentially relevant sigma and serotonin receptor affinity in membrane preparations
Michael T. Scerba, David Tweedie, Nigel H. Greig
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 110, pp. 129885-129885
Open Access
MAMs and Mitochondrial Quality Control: Overview and Their Role in Alzheimer’s Disease
Jian-Sheng Luo, Wen-Hu Zhai, Lingling Ding, et al.
Neurochemical Research (2024) Vol. 49, Iss. 10, pp. 2682-2698
Closed Access
Tricyclic Antidepressant Amitriptyline Suppresses Ca2+ Responses in Rat Peritoneal Macrophages
L. S. Milenina, Z. I. Krutetskaya, В. Г. Антонов, et al.
Cell and Tissue Biology (2024) Vol. 18, Iss. 4, pp. 439-450
Closed Access
Clinical Update on an Anti-Alzheimer Drug Candidate CT1812: A Sigma-2 Receptor Antagonist
Guramrit Kaur, Zahid Ahmad Dar, Ankit Bajpai, et al.
Clinical Therapeutics (2024)
Closed Access
CT1812, a Small Molecule Sigma-2 Receptor Antagonist for Alzheimer’s Disease Treatment: A Systematic Review of Available Clinical Data
Premrutai Thitilertdecha, James Michael Brimson
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S115-S128
Closed Access
Future Therapeutic Strategies for Alzheimer’s Disease: Focus on Behavioral and Psychological Symptoms
Kyoung Ja Kwon, Hahn Young Kim, Seol‐Heui Han, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11338-11338
Open Access
Page 1 - Next Page

Scroll to top